We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+11.95%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.41B
AUM Growth
+$131M
(+3.1%)
Cap. Flow
-$472M
Cap. Flow
% of AUM
-10.71%
Top 10 Holdings %
Top 10 Hldgs %
31.99%
Holding
983
New
316
Increased
242
Reduced
174
Closed
237
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$145M |
| 2 |
Amgen
AMGN
|
+$84.8M |
| 3 |
Perrigo
PRGO
|
+$60.8M |
| 4 |
Tenet Healthcare
THC
|
+$53.5M |
| 5 |
Cardinal Health
CAH
|
+$41.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$132M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$80.9M |
| 3 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$65M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$65M |
| 5 |
Gilead Sciences
GILD
|
+$51.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.02% |
| 2 | Consumer Staples | 4.24% |
| 3 | Consumer Discretionary | 4.22% |
| 4 | Industrials | 3.96% |
| 5 | Utilities | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTSI
76
DELISTED
HARRIS TEETER SUPERMARKETS INC COM STK (NC)
HTSI
| $9.38M | 0.21% |
+190,744
| New | +$9.37M |
|
|
QLTI
77
DELISTED
QLT Inc
QLTI
| $9.26M | 0.21% |
2,000,000
+500,000
| +33% | +$2.17M |
|
78
Roper Technologies
ROP
$38.8B
| $9.22M | 0.21% |
+69,374
| New | +$8.91M |
|
79
Wabtec
WAB
$49.1B
| $9.18M | 0.21% |
145,950
+47,780
| +49% | +$2.8M |
|
|
JAH
80
DELISTED
JARDEN CORPORATION
JAH
| $9M | 0.2% |
278,954
+172,571
| +162% | +$5.32M |
|
81
Bio-Rad Laboratories Class A
BIO
$8.71B
| $8.96M | 0.2% |
76,208
+42,066
| +123% | +$4.96M |
|
|
HOLX
82
DELISTED
Hologic
HOLX
| $8.94M | 0.2% |
432,885
+389,739
| +903% | +$8.3M |
|
83
IDEX
IEX
$17B
| $8.74M | 0.2% |
133,899
+42,453
| +46% | +$2.57M |
|
84
Pfizer
PFE
$143B
| $8.67M | 0.2% |
318,145
-281,586
| -47% | -$7.66M |
|
|
STJ
85
DELISTED
St Jude Medical
STJ
| $8.5M | 0.19% |
158,469
+138,850
| +708% | +$7.15M |
|
86
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $8.4M | 0.19% |
+500
| New | +$83.8K |
|
|
87
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $8.4M | 0.19% |
+500
| New | +$83.8K |
|
88
Standard BioTools
LAB
$340M
| $8.1M | 0.18% |
368,957
+68,057
| +23% | +$1.34M |
|
|
TRW
89
DELISTED
TRW AUTOMOTIVE HOLDINGS CORP
TRW
| $8.09M | 0.18% |
113,460
+45,979
| +68% | +$3.23M |
|
90
PUT
Illumina
ILMN
$31B
| $8.08M | 0.18% |
+1,028
| New | +$78.6K |
|
91
Vodafone
VOD
$36.3B
| $7.97M | 0.18% |
222,119
+137,342
| +162% | +$4.34M |
|
|
MAKO
92
DELISTED
MAKO SURGICAL CORP COM
MAKO
| $7.8M | 0.18% |
264,366
-131,137
| -33% | -$2M |
|
93
LyondellBasell Industries
LYB
$20B
| $7.77M | 0.18% |
106,118
+51,442
| +94% | +$3.58M |
|
|
LEAP
94
PUT
DELISTED
LEAP WIRELESS INTERNATIONAL INC NEW
LEAP
| $7.73M | 0.18% |
+4,894
| New | +$72.9K |
|
95
Novartis
NVS
$297B
| $7.72M | 0.18% |
112,271
+31,772
| +39% | +$2.1M |
|
96
Lear
LEA
$6.54B
| $7.71M | 0.17% |
107,725
+67,725
| +169% | +$4.66M |
|
97
CVS Health
CVS
$133B
| $7.63M | 0.17% |
134,387
+32,604
| +32% | +$1.94M |
|
98
Exelixis
EXEL
$13.3B
| $7.57M | 0.17% |
+1,300,000
| New | +$6.73M |
|
99
Apple
AAPL
$4.54T
| $7.54M | 0.17% |
443,156
-623,476
| -58% | -$10.3M |
|
|
ELGX
100
DELISTED
Endologix Inc
ELGX
| $7.54M | 0.17% |
46,718
+7,992
| +21% | +$1.26M |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q3 2013 Portfolio in Review
As of Q3 2013, Visium Asset Management held 983 positions worth $4.41B, up 3.1% from $4.28B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management withdrew a net $472M in Q3 2013, closing 237 positions and reducing 174 holdings. Its most notable exit was Bausch Health, an estimated $132M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 48% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
Against the trend, Visium Asset Management opened a new position in Brookdale Senior Living worth $37.5M.
- Visium Asset Management's largest Q3 2013 buy was Brookdale Senior Living: 1,426,060 shares worth $37.5M.
- Visium Asset Management added most to Allergan Inc in Q3 2013, an estimated $145M increase.
- Visium Asset Management's biggest Q3 2013 reduction was Endo International plc, cutting an estimated $80.9M.
- Visium Asset Management fully exited Bausch Health in Q3 2013, selling an estimated $132M.
- Visium Asset Management's ten largest holdings make up 32% of its $4.41B portfolio in Q3 2013.
- Visium Asset Management opened 316 new positions and closed 237 in Q3 2013.
- Visium Asset Management's portfolio value rose 3.1% quarter-over-quarter to $4.41B.
Based on Visium Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.